Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01703429 · ClinicalTrials.gov registry record

Complementary and Alternative Care in Multiple Sclerosis

A clinical trial of Multiple Sclerosis, sponsored by Bastyr University.

Recruiting
Registry status
1,000
Enrollment target
1
Study location

NCT01703429: Recruiting study of Multiple Sclerosis, sponsored by Bastyr University.

NCT01703429 is a study of Multiple Sclerosis that is actively recruiting participants, run by Bastyr University. The registered enrollment target is 1,000 participants, above the 582-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (72% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01703429, a study of Multiple Sclerosis, is actively recruiting participants, sponsored by Bastyr University.

RECRUITING
Registry status
1,000 participants
Enrollment target
1
Study location

Study Summary

This is a prospective, observational study designed to describe disease progression, symptom change, quality of life, diet and lifestyle habits, and frequency of adverse events among patients with multiple sclerosis (MS) who use complementary and alternative medicine (CAM). In addition to describing the patterns of CAM use, this study will also identify and describe the positive deviants, those individuals with the highest quality of life and least amount of disease activity. Positive deviants will be compared to controls in order to describe medication, diet, and lifestyle patterns associated with a lack of MS disease progression and high quality of life.

Primary Outcome

This survey has been developed to identify the complementary and alternative therapies most commonly used by individuals with MS. Results will be reported with descriptive statistics.

Conditions Studied

Multiple Sclerosis

Study Locations (1)

Washington

  • Bastyr University Clinical Research Center - Kenmore

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2012-06
Est. Completion 2030-06
Bastyr University

19 total trials

What NCT01703429 shows while recruiting

NCT01703429 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 582-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (72% higher).

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 0 interventions.

NCT01703429 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT01703429 about?

NCT01703429 is a clinical study titled "Complementary and Alternative Care in Multiple Sclerosis". This is a prospective, observational study designed to describe disease progression, symptom change, quality of life, diet and lifestyle habits, and frequency of adverse events among patients with multiple sclerosis (MS) who use complementary and alternative medicine (CAM). In addition to describing...

What is the current status of trial NCT01703429?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2012-06. Estimated completion is 2030-06.

What conditions does trial NCT01703429 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

Who is sponsoring clinical trial NCT01703429?

This trial is sponsored by Bastyr University, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01703429 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01703429's enrollment target sits among peer trials

1,000 26th of 315 higher than 287 of 315 other Multiple Sclerosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

More recruiting context for NCT01703429

Source: ClinicalTrials.gov NCT01703429, the US trial registry maintained by the National Library of Medicine. NCT01703429 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.